Now part of Biobeat’s FDA-cleared, cuffless 24/7 hypertension monitoring platform – delivering more precise, personalized, and efficient care.
Biobeat announces the launch of its latest app update, introducing the Patient Diary-a powerful new addition to its FDA-cleared, cuffless 24-hour blood pressure monitoring platform. This feature marks an important step forward in Biobeat’s mission to empower clinicians with richer insights and make hypertension diagnosis and management more precise, personalized, and efficient.
With the Patient Diary, patients can now actively participate in their own monitoring process by logging medications, exercise, meals, sleep, mood, stress, and health events directly in the Biobeat App during their 24-hour blood pressure assessment. This easy-to-use diary transforms the monitoring experience into an interactive, data-rich process, capturing both physical measurements and personal patient inputs.
By integrating these two data streams, validated blood pressure readings and real-world patient observations, Biobeat enables a more comprehensive and contextualized blood pressure picture. Physicians can now see not only how a patient’s blood pressure behaves throughout the day and night, but also what might be influencing those fluctuations. Whether it is a meal, physical activity, emotional stress, or sleep quality, these factors can now be directly correlated with physiological changes, helping clinicians uncover patterns that were previously hidden in traditional 24-hour monitoring.
This enhanced clinical view supports more confident, data-driven decision-making in hypertension diagnosis and management. It reduces reliance on retrospective reports and fragmented patient recollections, allowing for a more accurate understanding of individual responses to lifestyle, medication, and treatment plans. For chronic hypertension care, this means a more dynamic, tailored, and proactive approach-one that supports earlier intervention and improved outcomes.
Trusted by healthcare systems and research institutions worldwide, Biobeat’s cuffless, wearable technology continues to redefine how clinicians monitor and manage blood pressure. The introduction of the Patient Diary builds on Biobeat’s core platform, strengthening its role as a comprehensive, actionable, and patient-centered monitoring solution.
By bridging the gap between patient experience and physiological data, Biobeat moves one step closer to its vision of truly personalized hypertension management-where every data point tells a story, and every story helps shape better care.
Meet our team at AHA Scientific Sessions 2025 or Kidney Week 2025 to and learn more
